Author + information
- Shuiqing Zhu,
- Milun Zhang,
- Qian Ni,
- Qiao Sun and
- Jianwei Xuan
Background: Heart failure patients are frequently hospitalized, leading to significant treatment burden. The study aims to examine the treatment cost of HF hospitalization by NYHA class to provide real-world data in understanding the economic burden of HF inpatient care in China.
Methods: This is a multicenter chart review study with patient samples collected from the cardiology/cardiac surgery departments of 8 hospitals in four major cities in China. Adult patients with primary diagnosis of heart failure, NYHA classification and ≥1 hospitalization record from March 3rd 2015 to May 24th 2016 were included. Total hospitalization expenditure by NYHA classification, length of stay (LOS), and comorbidity condition were examined. Patients underwent surgeries during hospitalization were analyzed in subgroup.
Results: A total of 363 HF patients met the study criteria (mean age 69.65±13.28; 53.74% male). 27.30%, 19.25%, and 53.45% of patients were diagnosed as HF with reduced ejection fraction (HFrEF), HF with mid-range ejection fraction (HFmrEF), and HF with preserved ejection fraction (HFpEF) respectively. The average expenditure per HF hospitalization was 39,064CNY, and was increased by NYHA classification at 6,943CNY, 26,097CNY, 45,079CNY, 48,800CNY, 47,531CNY, 42,489CNY with NYHA I, II, II-III, III, III-IV and IV respectively (ANOVA test: P<0.050). 25.34% of patients underwent surgeries with average total hospitalization expenditure up to 102,268CNY. The mean LOS was 14.07 days. 71.35% of patients had more than three comorbidities, of which hypertension, coronary heart disease, and lung disease were most prevalent.
Conclusions: The mean cost per HF hospitalization much higher than the average disposable annual income per capita in China in 2015 (21,966CNY) and is increased by NYHA class, imposing significant economic burden to HF patients. Moreover, surgery is one major driver of the high hospitalization expenditure. This study highlights the critical need to introduce innovative therapy that effectively reduces hospitalization and prevents worsening of symptoms for HF patients in China.
Poster Hall, Hall C
Friday, March 17, 2017, 10:00 a.m.-10:45 a.m.
Session Title: Population Specific Cardiomyopathies: From Exomes to Databases
Abstract Category: 12. Heart Failure and Cardiomyopathies: Basic
Presentation Number: 1122-261
- 2017 American College of Cardiology Foundation